Dolutegravir Use at Conception - Additional Surveillance Data from Botswana.
作者信息
Raesima Mmakgomo M, Ogbuabo Chibuike M, Thomas Vasavi, Forhan Sara E, Gokatweng Gadzikanani, Dintwa Eldah, Petlo Chipo, Motswere-Chirwa Catherine, Rabold Elizabeth M, Tinker Sarah C, Odunsi Shifawu, Malima Sifelani, Mmunyane Omphemetse, Modise Thusoetsile, Kefitlhile Kelame, Dare Kunle, Letebele Mpho, Roland Michelle E, Moore Cynthia A, Modi Surbhi, Williamson Dhelia M
机构信息
Botswana Ministry of Health and Wellness, Gaborone, Botswana.
Botswana-University of Maryland School of Medicine Health Initiative, Gaborone, Botswana.
出版信息
N Engl J Med. 2019 Aug 29;381(9):885-887. doi: 10.1056/NEJMc1908155. Epub 2019 Jul 22.
Abstract
摘要
相似文献
1
Dolutegravir Use at Conception - Additional Surveillance Data from Botswana.多替拉韦在受孕时的使用——来自博茨瓦纳的更多监测数据。
N Engl J Med. 2019 Aug 29;381(9):885-887. doi: 10.1056/NEJMc1908155. Epub 2019 Jul 22.
2
Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana.博茨瓦纳的神经管缺陷和抗逆转录病毒治疗方案。
N Engl J Med. 2019 Aug 29;381(9):827-840. doi: 10.1056/NEJMoa1905230. Epub 2019 Jul 22.
3
Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception.受孕时使用多替拉韦治疗导致的神经管缺陷。
N Engl J Med. 2018 Sep 6;379(10):979-981. doi: 10.1056/NEJMc1807653. Epub 2018 Jul 24.
4
HIV Drug May Increase Risk of Neural Tube Birth Defects.抗艾滋病病毒药物可能会增加神经管出生缺陷的风险。
Am J Nurs. 2019 Jan;119(1):27. doi: 10.1097/01.NAJ.0000552605.35664.bc.
5
Dolutegravir becomes first choice for HIV.多替拉韦成为治疗艾滋病病毒的首选药物。
Lancet Infect Dis. 2019 Sep;19(9):937-938. doi: 10.1016/S1473-3099(19)30438-4.
6
Dolutegravir for pregnant women living with HIV.多替拉韦用于感染艾滋病毒的孕妇。
CMAJ. 2020 Mar 2;192(9):E217-E218. doi: 10.1503/cmaj.191227.
7
Changes to dolutegravir policy in several African countries.非洲几个国家多替拉韦政策的变化。
Lancet. 2018 Jul 21;392(10143):199. doi: 10.1016/S0140-6736(18)31641-6.
8
Periconception dolutegravir use in women living with HIV and missed opportunities in maternal and child health.感染艾滋病毒的妇女在受孕前后使用多替拉韦的情况以及母婴健康方面错失的机会。
Lancet Child Adolesc Health. 2019 Oct;3(10):669-671. doi: 10.1016/S2352-4642(19)30245-7. Epub 2019 Jul 30.
9
Dolutegravir and pregnancy outcomes in women on antiretroviral therapy in Brazil: a retrospective national cohort study.多替拉韦与巴西抗逆转录病毒治疗女性的妊娠结局：一项回顾性全国队列研究。
Lancet HIV. 2021 Jan;8(1):e33-e41. doi: 10.1016/S2352-3018(20)30268-X.
10
Clinical Extrapolation of the Effects of Dolutegravir and Other HIV Integrase Inhibitors on Folate Transport Pathways.多替拉韦及其他 HIV 整合酶抑制剂对叶酸转运途径影响的临床外推。
Drug Metab Dispos. 2019 Aug;47(8):890-898. doi: 10.1124/dmd.119.087635. Epub 2019 Jun 5.
引用本文的文献
1
Obstetric and newborn outcomes of mothers with and without HIV infection in Anaka general hospital in Northern Uganda.乌干达北部阿纳卡综合医院感染和未感染艾滋病毒母亲的产科及新生儿结局
PLoS One. 2025 Jun 17;20(6):e0326322. doi: 10.1371/journal.pone.0326322. eCollection 2025.
2
Integrase inhibitor drugs during pregnancy and congenital anomalies: A case/non-case study from the global pharmacovigilance database VigiBase®.孕期使用整合酶抑制剂药物与先天性异常：来自全球药物警戒数据库VigiBase®的病例/非病例研究
Pharmacol Res Perspect. 2024 Aug;12(4):e1247. doi: 10.1002/prp2.1247.
3
Metabolic implications and safety of dolutegravir use in pregnancy.妊娠期使用度鲁特韦的代谢影响及其安全性。
Lancet HIV. 2023 Sep;10(9):e606-e616. doi: 10.1016/S2352-3018(23)00141-8. Epub 2023 Aug 4.
4
The burden, prevention and care of infants and children with congenital anomalies in sub-Saharan Africa: A scoping review.撒哈拉以南非洲地区先天性异常婴幼儿的负担、预防与护理：一项范围综述
PLOS Glob Public Health. 2023 Jun 28;3(6):e0001850. doi: 10.1371/journal.pgph.0001850. eCollection 2023.
5
The End Is in Sight: Current Strategies for the Elimination of HIV Vertical Transmission.曙光初现：消除 HIV 垂直传播的当前策略。
Curr HIV/AIDS Rep. 2023 Jun;20(3):121-130. doi: 10.1007/s11904-023-00655-z. Epub 2023 Mar 27.
6
HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis.人类免疫缺陷病毒1型整合酶耐药相关突变及多替拉韦在撒哈拉以南非洲地区的应用：一项系统评价与荟萃分析
PLOS Glob Public Health. 2022 Oct 11;2(10):e0000826. doi: 10.1371/journal.pgph.0000826. eCollection 2022.
7
Inhibition of matrix metalloproteinases by HIV-1 integrase strand transfer inhibitors.HIV-1整合酶链转移抑制剂对基质金属蛋白酶的抑制作用
Front Toxicol. 2023 Feb 21;5:1113032. doi: 10.3389/ftox.2023.1113032. eCollection 2023.
8
Antiretroviral Options and Treatment Decisions During Pregnancy.孕期抗逆转录病毒治疗方案与治疗决策
Paediatr Drugs. 2023 May;25(3):267-282. doi: 10.1007/s40272-023-00559-w. Epub 2023 Feb 2.
9
HIV-1 Integrase Strand Transfer Inhibitors and Neurodevelopment.HIV-1整合酶链转移抑制剂与神经发育
Pharmaceuticals (Basel). 2022 Dec 9;15(12):1533. doi: 10.3390/ph15121533.
10
A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection.HIV 整合酶链转移抑制剂（INSTIs）在预防和治疗 HIV-1 感染方面的临床评价。
Retrovirology. 2022 Oct 22;19(1):22. doi: 10.1186/s12977-022-00608-1.
本文引用的文献
1
Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana.博茨瓦纳的神经管缺陷和抗逆转录病毒治疗方案。
N Engl J Med. 2019 Aug 29;381(9):827-840. doi: 10.1056/NEJMoa1905230. Epub 2019 Jul 22.
2
Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception.受孕时使用多替拉韦治疗导致的神经管缺陷。
N Engl J Med. 2018 Sep 6;379(10):979-981. doi: 10.1056/NEJMc1807653. Epub 2018 Jul 24.
3
Simple SAS macros for the calculation of exact binomial and Poisson confidence limits.用于计算精确二项式和泊松置信区间的简单SAS宏。
Comput Biol Med. 1992 Sep;22(5):351-61. doi: 10.1016/0010-4825(92)90023-g.
Zotero 插件